House passes bill to combat flow of opioids into US

Legislation to beef up U.S. Customs and Border Protection’s (CBP) ability to detect attempts to smuggle opioids into the country passed in the House on Tuesday.

The House voted 412-3 to approve the bill, which would authorize $9 million to ensure the CBP has chemical screening devices, scientists and other personnel available to detect the illegal importation of fentanyl and other synthetic opioids.

“The federal government must do its part to ensure our first responders have the tools they need in this greatest of public health fights,” said Rep. Niki Tsongas (D-Mass.), who authored the legislation with Rep. Brian Fitzpatrick (R-Pa.).

ADVERTISEMENT

Fentanyl is estimated to be up to 50 times stronger than heroin and is mostly imported into the U.S. from Mexico or China. It's typically smuggled across the U.S. border or delivered via mail, as it can be ordered online.

Generally, fentanyl is distributed in small amounts due to its potency, which makes it harder for law enforcement to detect it at checkpoints.

Sen. Ed MarkeyEdward (Ed) John MarkeyTo make the House of Representatives work again, make it bigger Dems urge tech companies to remove 3D-gun blueprints Make the moon a refueling station — then head to Mars MORE (D-Mass.), Sherrod BrownSherrod Campbell BrownThe Hill's Morning Report — Trump’s GOP feuds dominate ahead of midterms Dustbin 2020: The best Dems who surely won’t get the nomination Vulnerable Dems side with Warren in battle over consumer bureau MORE (D-Ohio), Marco RubioMarco Antonio RubioGOP lawmakers raise concerns over research grants to colleges with Confucius Institutes Paid family leave could give new parents a much-needed lifeline GOP looks to injure Nelson over Russia comments MORE (R-Fla.) and Shelley Moore CapitoShelley Wellons Moore CapitoSenate GOP battles for leverage with House on spending Lawmakers, media team up for charity tennis event The Hill's Morning Report — Trump picks new fight with law enforcement, intelligence community MORE (R-W.Va.) have introduced bipartisan companion legislation in the Senate.

Passage of the bill came a week after a Washington Post and "60 Minutes" joint investigation found that Congress had passed a bill in 2016 that hindered the Drug Enforcement Administration’s (DEA) efforts to combat the opioid crisis.

Rep. Tom Marino (R-Pa.) withdrew his name for consideration as President Trump’s drug czar after the investigation revealed his role in pushing the bill, which made it harder for the DEA to stop prescription opioids from being supplied to doctors and pharmacists suspected of selling narcotics on the black market.